In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...
Rival European pharma giants Sanofi and GSK have both forged new partnerships to bolster their preclinical research. | Rival ...
PharmAla Biotech Holdings Inc. ('PharmAla” or the 'Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules ...
The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...
Provisions on research security, grant policies, indirect cost rates, and more are packed into the latest version of the NDAA ...
Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...
Collaboration will combine Zealand Pharma's expertise in obesity and metabolic health with OTR Therapeutics' proprietary oral ...
The coming era of biosecurity will demand a broader and more adaptive approach as AI, powerful biological engineering ...
Jacksonville Journal-Courier on MSNOpinion
Commentary: America surrendering its biotech crown — Karen Kerrigan
Commentary: Health and Human Services justified its decision by citing public mistrust in vaccines based on mRNA technology, ...
TipRanks on MSN
PharmAla Biotech advances with Australian-made MDMA capsules
PharmAla Biotech Holdings, Inc. ( ($TSE:MDMA) ) has shared an update. PharmAla Biotech Holdings Inc. has completed release ...
Visakhapatnam: Though 11 years have passed since the bifurcation of combined Andhra Pradesh, the residuary state still lacks ...
The "Plant Breeding and CRISPR Plants - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Plant Breeding and CRISPR Plants was valued at US$21 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results